Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI
  • Top
  • Version history

Advertisement

Corrigendum Free access | 10.1172/JCI77956

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

Enoch Muyanja,1 Aloysius Ssemaganda,1 Pearline Ngauv,2 Rafael Cubas,2 Helene Perrin,2 Divya Srinivasan,2 Glenda Canderan,2 Benton Lawson,3 Jakub Kopycinski,4 Amanda S. Graham,5 Dawne K. Rowe,5 Michaela J. Smith,5 Denis Gaucher,6 Sharon Isern,5 Scott Michael,5 Guido Silvestri,3 Thomas H. Vanderford,3 Erika Castro,7 Giuseppe Pantaleo,7,8 Joel Singer,9 Jill Gillmour,4 Noah Kiwanuka,1,10 Annet Nanvubya,1 Claudia Schmidt,11 Josephine Birungi,1 Josephine Cox,4 Elias K. Haddad,2 Pontiano Kaleebu,1,12 Patricia Fast,11 Rafick-Pierre Sekaly,2 and Lydie Trautmann2

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Muyanja, E. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Ssemaganda, A. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Ngauv, P. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Cubas, R. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Perrin, H. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Srinivasan, D. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Canderan, G. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Lawson, B. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Kopycinski, J. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Graham, A. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Rowe, D. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Smith, M. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Gaucher, D. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Isern, S. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Michael, S. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Silvestri, G. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Vanderford, T. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Castro, E. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Pantaleo, G. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Singer, J. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Gillmour, J. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Kiwanuka, N. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Nanvubya, A. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Schmidt, C. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Birungi, J. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Cox, J. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Haddad, E. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Kaleebu, P. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Fast, P. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Sekaly, R. in: JCI | PubMed | Google Scholar

1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.

Find articles by Trautmann, L. in: JCI | PubMed | Google Scholar

First published October 1, 2014 - More info

Published in Volume 124, Issue 10 on October 1, 2014
J Clin Invest. 2014;124(10):1–1. https://doi.org/10.1172/JCI77956.
Copyright © 2014, American Society for Clinical Investigation
First published October 1, 2014 - Version history

Original citation: J Clin Invest. 2014;124(7):3147–3158. doi:10.1172/JCI75429.

Citation for this corrigendum: J Clin Invest. 2014;124(10):4669. doi:10.1172/JCI77956.

Denis Gaucher was omitted from the author list. In addition, affiliations were omitted for Noah Kiwanuka and Pontiano Kaleebu, Claudia Schmidt’s affiliation was incorrect, and affiliation numbers 4 and 7 were incomplete. The correct author and affiliation lists are above.

The authors regret the error.

Version history
  • Version 1 (October 1, 2014): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI

Go to:

  • Top
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts